Infectopharm Arzneimittel GmbH   Report issue

For profit Phase 3
Founded: Heppenheim Germany (1988)
Status: No NME R&D (1988)

Organization Overview

First Clinical Trial
2020
NCT04552327
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Infectopharm Arzneimittel GmbH

Active Ingredients

Drugs in Phase 3 Trials (3)

diclofenac (voltaren) (1 trial)

ivermectin (stromectol) (2 trials)

permethrin (nix) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Keratosis (Phase 3)

Keratosis, Actinic (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 3